Readily available biomarkers can help to identify patients with worst prognosis in metastatic pancreatic cancer. (2020) - Strijker, M.; Van Veldhuisen, E.; Van der Geest, L.; Busch, O.; Mohammad, N Haj; Homs, M.; Van Hooft, J.; Lemmens, V.; Verheij, J.; De Vos-Geelen, J.; Wilmink, J.; Besselink, M.; et al.